The Choice of Initial Configurations in Multidimensional Scaling: Local Minima, Fit, and Interpretability
Austrian Journal of Statistics · 04.01.2017 · 46 (2) · 19-32
DOI: 10.17713/ajs.v46i2.561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Austrian Journal of Statistics, online erschienen am 04.01.2017. Verfasst von Ingwer Borg und 1 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref).
Abstract (Originalsprache)
Multidimensional scaling (MDS) algorithms can easily end up in local minima, depending on the starting configuration. This is particularly true for 2-dimensional ordinal MDS. A simulation study shows that there can be many local minima that all have an excellent model fit (i.e., small Stress) even if they do not recover a known latent configuration very well, and even if they differ substantially among each other. MDS programs give the user only one supposedly Stress-optimal solution. We here present a procedure for analyzing all MDS solutions resulting from using a variety of different starting configurations. The solutions are compared in terms of fit and configurational similarity. This allows the MDS user to identify different types of solutions with acceptable Stress, if they exist, and then pick the one that is best interpretable.
Zitieren
APA
Borg, I., & Mair, P. (2017). The Choice of Initial Configurations in Multidimensional Scaling: Local Minima, Fit, and Interpretability. Austrian Journal of Statistics, 46(2), 19-32. https://doi.org/10.17713/ajs.v46i2.561
Vancouver
Borg I, Mair P. The Choice of Initial Configurations in Multidimensional Scaling: Local Minima, Fit, and Interpretability. Austrian Journal of Statistics. 2017;46(2):19-32. doi:10.17713/ajs.v46i2.561
BibTeX
@article{Borg2017,
author = {Borg, Ingwer and Mair, Patrick},
title = {The Choice of Initial Configurations in Multidimensional Scaling: Local Minima, Fit, and Interpretability},
journal = {Austrian Journal of Statistics},
year = {2017},
volume = {46},
number = {2},
pages = {19--32},
doi = {10.17713/ajs.v46i2.561}
}
EUVIMED